by Asmaa Javed | Dec 30, 2022 | Press Releases
Cobimetinib is an anti-cancer medication that was first approved for the treatment of melanomas.
by Asmaa Javed | Dec 30, 2021 | Press Releases
Erasmus University Medical Center in Rotterdam joins a network of hospitals skilled in treating Erdheim-Chester disease patients.
by Asmaa Javed | Dec 30, 2021 | Press Releases
New clinical practice guidelines from National Comprehensive Cancer Network focus on workup and management for three main adult histiocytic disorders.
by Asmaa Javed | Dec 30, 2021 | Press Releases
The Erdheim-Chester Disease Global Alliance is proud to announce the first ECD Referral Care Center to be located in Michigan.
by Asmaa Javed | Dec 30, 2021 | Press Releases
Tuesday, November 16, 2021: During this conference, medical professionals from around the world gathered to share scientific findings, patient outcomes, and case studies related to Erdheim-Chester Disease and other histiocytic disorders.
